N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic Adenocarcinoma.
Thorvardur R HalfdanarsonNathan R FosterGeorge P KimMichael G HaddockShaker R DakhilRobert J BehrensSteven R AlbertsPublished in: The oncologist (2022)
The combination of panitumumab, chemotherapy, and external beam radiation therapy was associated with very high rates of grades 3-4 toxicities and survival results did not meet the trial's goal for success. This regimen is not recommended for further study (ClinicalTrials.gov Identifier NCT00601627).